These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 12657367)

  • 21. Neuro-optic cell apoptosis and microangiopathy in KKAY mouse retina.
    Ning X; Baoyu Q; Yuzhen L; Shuli S; Reed E; Li QQ
    Int J Mol Med; 2004 Jan; 13(1):87-92. PubMed ID: 14654976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diabetic retinopathy. Current opinion on pathophysiology, diagnostics and therapy].
    Sacha E
    Przegl Lek; 2005; 62(4):238-42. PubMed ID: 16229243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives.
    Simó R; Hernández C;
    Trends Endocrinol Metab; 2014 Jan; 25(1):23-33. PubMed ID: 24183659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular mechanisms of vasculogenesis and angiogenesis. What regulates vascular growth?].
    Joussen AM; Kirchhof B; Gottstein C
    Ophthalmologe; 2003 Apr; 100(4):284-91. PubMed ID: 12682760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes and retinal vascular disorders: role of the renin-angiotensin system.
    Wilkinson-Berka JL
    Expert Rev Mol Med; 2004 Jul; 6(15):1-18. PubMed ID: 15387897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
    Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New concepts on diabetic retinopathy: neural versus vascular damage].
    Serrarbassa PD; Dias AF; Vieira MF
    Arq Bras Oftalmol; 2008; 71(3):459-63. PubMed ID: 18641842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI retinovascular studies in humans: research in patients with diabetes.
    Trick GL; Edwards PA; Desai U; Morton PE; Latif Z; Berkowitz BA
    NMR Biomed; 2008 Nov; 21(9):1003-12. PubMed ID: 18821575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of vascular endothelial growth factor and down-regulation of pigment epithelium-derived factor messenger ribonucleic acid levels in leptin-exposed cultured retinal pericytes.
    Yamagishi S; Inagaki Y; Amano S; Okamoto T; Takeuchi M
    Int J Tissue React; 2002; 24(4):137-42. PubMed ID: 12779248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.
    Funatsu H; Yamashita H; Ikeda T; Mimura T; Eguchi S; Hori S
    Ophthalmology; 2003 Sep; 110(9):1690-6. PubMed ID: 13129863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic retinopathy: recent advances towards understanding neurodegeneration and vision loss.
    Barber AJ
    Sci China Life Sci; 2015 Jun; 58(6):541-9. PubMed ID: 25951929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.
    Caldwell RB; Bartoli M; Behzadian MA; El-Remessy AE; Al-Shabrawey M; Platt DH; Caldwell RW
    Diabetes Metab Res Rev; 2003; 19(6):442-55. PubMed ID: 14648803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Glucose metabolism in vascular endothelial cells].
    Yokota C; Okuda Y
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():324-30. PubMed ID: 12238067
    [No Abstract]   [Full Text] [Related]  

  • 34. Retinal Cell Damage in Diabetic Retinopathy.
    Zhou J; Chen B
    Cells; 2023 May; 12(9):. PubMed ID: 37174742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuron-derived semaphorin 3A is an early inducer of vascular permeability in diabetic retinopathy via neuropilin-1.
    Cerani A; Tetreault N; Menard C; Lapalme E; Patel C; Sitaras N; Beaudoin F; Leboeuf D; De Guire V; Binet F; Dejda A; Rezende FA; Miloudi K; Sapieha P
    Cell Metab; 2013 Oct; 18(4):505-18. PubMed ID: 24093675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far.
    Whitmire W; Al-Gayyar MM; Abdelsaid M; Yousufzai BK; El-Remessy AB
    Mol Vis; 2011 Jan; 17():300-8. PubMed ID: 21293735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mechanisms of retinal neurodegeneration as a result of diabetes mellitus].
    Lang GE
    Klin Monbl Augenheilkd; 2013 Sep; 230(9):929-31. PubMed ID: 23986191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The state of ocular neurosensory apparatus in diabetes mellitus].
    Sdobnikova SV; Kulybysheva VS; Sidamonidze AL
    Vestn Oftalmol; 2018; 134(5. Vyp. 2):263-269. PubMed ID: 30499527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications.
    Simó R; Hernández C;
    Br J Ophthalmol; 2012 Oct; 96(10):1285-90. PubMed ID: 22887976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genes and diabetic retinopathy.
    Radha V; Rema M; Mohan V
    Indian J Ophthalmol; 2002 Mar; 50(1):5-11. PubMed ID: 12090088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.